OIG slaps PharMerica with $21.8 million kickback penalty

News
Article

Office of Inspector General isues demand letter to PharMerica Drug Systems based on alleged kickback violations, damages total $21.8 million

Newsletter

Pharmacy practice is always changing. Stay ahead of the curve with the Drug Topics newsletter and get the latest drug information, industry trends, and patient care tips.

Subscribe Now!
Recent Videos
Related Content
FDA Approves First Generic GLP-1 Liraglutide for Weight Loss

FDA Approves First Generic GLP-1 Liraglutide for Weight Loss

Ashley Gallagher
August 30th 2025
Article
Over the Counter podcast

Episode 8: Stay in Sync with Innovations in Medication Decision Support

Drug Topics staff
August 30th 2025
Podcast
FDA Approves Updated 2025-2026 COVID-19 Vaccine for Patients 65 Years and Older

FDA Approves Updated 2025-2026 COVID-19 Vaccine for Patients 65 Years and Older

Ashley Gallagher
August 30th 2025
Article
FDA Expands Approval of Evolocumab to Include Patients at Increased Risk of MACE

FDA Expands Approval of Evolocumab to Include Patients at Increased Risk of MACE

Ashley Gallagher
August 30th 2025
Article
FDA Approves Cyclobenzaprine Sublingual Tablets for Treatment of Fibromyalgia

FDA Approves Cyclobenzaprine Sublingual Tablets for Treatment of Fibromyalgia

Ashley Gallagher
August 30th 2025
Article
FDA Approves Semaglutide to Treat MASH With Moderate to Advanced Fibrosis

FDA Approves Semaglutide to Treat MASH With Moderate to Advanced Fibrosis

Ashley Gallagher
August 30th 2025
Article
© 2025 MJH Life Sciences

All rights reserved.